Seer, Inc. (SEER) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Seer, Inc. (SEER) closed at USD 2.04 on 2026-10-15, a change of -8.1 % over the past year, with a market capitalization of USD 112.41M.

Seer, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Seer, Inc. key figures

Previous close

USD 2.04 (2026-10-15)

1-year change

-8.1 %

Market cap

USD 112.41M

Enterprise value

USD -18.06M

P/E ratio (trailing)

-1.66

P/E ratio (forward)

-1.92

EPS (trailing)

-1.22

EPS (forward)

-1.06

PEG ratio

n/a

Price to book

0.50

Revenue growth

-23.4 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.40

Employees

124

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Seer, Inc.

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Seer, Inc. and compare it with other stocks.